Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Tenax Therapeutics stock | $1.09

Own Tenax Therapeutics stock in just a few minutes.

Fact checked

Tenax Therapeutics, Inc is a biotechnology business based in the US. Tenax Therapeutics shares (TENX) are listed on the NASDAQ and all prices are listed in US Dollars. Tenax Therapeutics employs 9 staff and has a market cap (total outstanding shares value) of USD$13.5 million.

How to buy shares in Tenax Therapeutics

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Tenax Therapeutics. Find the stock by name or ticker symbol: TENX. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Tenax Therapeutics reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$1.09, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Tenax Therapeutics, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Tenax Therapeutics. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Tenax Therapeutics share price

Use our graph to track the performance of TENX stocks over time.

Tenax Therapeutics shares at a glance

Information last updated 2020-12-09.
Latest market closeUSD$1.09
52-week rangeUSD$0.45 - USD$2.68
50-day moving average USD$1.059
200-day moving average USD$1.2383
Wall St. target priceUSD$3
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-3.945

Buy Tenax Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Tenax Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Tenax Therapeutics price performance over time

Historical closes compared with the close of $1.09 from 2020-12-09

1 week (2021-01-08) N/A
1 month (2020-12-15) N/A
3 months (2020-10-15) N/A
6 months (2020-07-15) N/A
1 year (2020-01-15) N/A
2 years (2019-01-15) N/A
3 years (2018-01-15) N/A
5 years (2016-01-15) N/A

Tenax Therapeutics financials

Gross profit TTM USD$0
Return on assets TTM -73.4%
Return on equity TTM -140.79%
Profit margin 0%
Book value $0.587
Market capitalisation USD$13.5 million

TTM: trailing 12 months

Shorting Tenax Therapeutics shares

There are currently 26,721 Tenax Therapeutics shares held short by investors – that's known as Tenax Therapeutics's "short interest". This figure is 65.3% down from 76,997 last month.

There are a few different ways that this level of interest in shorting Tenax Therapeutics shares can be evaluated.

Tenax Therapeutics's "short interest ratio" (SIR)

Tenax Therapeutics's "short interest ratio" (SIR) is the quantity of Tenax Therapeutics shares currently shorted divided by the average quantity of Tenax Therapeutics shares traded daily (recently around 133605). Tenax Therapeutics's SIR currently stands at 0.2. In other words for every 100,000 Tenax Therapeutics shares traded daily on the market, roughly 200 shares are currently held short.

However Tenax Therapeutics's short interest can also be evaluated against the total number of Tenax Therapeutics shares, or, against the total number of tradable Tenax Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Tenax Therapeutics's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Tenax Therapeutics shares in existence, roughly 0 shares are currently held short) or 0.0021% of the tradable shares (for every 100,000 tradable Tenax Therapeutics shares, roughly 2 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Tenax Therapeutics.

Find out more about how you can short Tenax Therapeutics stock.

Tenax Therapeutics share dividends

We're not expecting Tenax Therapeutics to pay a dividend over the next 12 months.

Have Tenax Therapeutics's shares ever split?

Tenax Therapeutics's shares were split on a 1:20 basis on 26 February 2018. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Tenax Therapeutics shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Tenax Therapeutics shares which in turn could have impacted Tenax Therapeutics's share price.

Tenax Therapeutics share price volatility

Over the last 12 months, Tenax Therapeutics's shares have ranged in value from as little as $0.45 up to $2.68. A popular way to gauge a stock's volatility is its "beta".

TENX.US volatility(beta: 2.28)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tenax Therapeutics's is 2.2845. This would suggest that Tenax Therapeutics's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Tenax Therapeutics overview

Tenax Therapeutics, Inc., a specialty pharmaceutical company, focuses on identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. The company focuses on the development and commercialization of pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion/5ml vial for use in the reduction of morbidity and mortality in cardiac surgery patients at risk for developing low cardiac output syndrome. It is also involved in initiating a Phase 2 clinical trial of levosimendan for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site